SCHEMBL985651

SCHEMBL985651

FCCCCCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1009362 1.00 TSHR (0.33)
SCHEMBL8020724 1.00
SCHEMBL7558589 1.00 TSHR (0.33)
SCHEMBL11072586 1.00 TSHR (0.33)
SCHEMBL9142636 1.00 TSHR (0.33)
SCHEMBL1798324 1.00
SCHEMBL18702356 1.00 TSHR (0.33)
SCHEMBL20957495 1.00 TSHR (0.33)
SCHEMBL21060944 1.00 TSHR (0.33)
SCHEMBL8602934 1.00 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137621-B Novel method for preparing aminosilane compounds 株式会社LG化学 2021-07-06 CN claimed
US-10556918-B2 Method for preparing aminosilane-based compound LG CHEM, LTD. (KR) 2020-02-11 US claimed
EP-3330273-B1 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND LG CHEMICAL LTD (KR) 2019-06-19 EP claimed
US-20180282353-A1 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND LG CHEM, LTD. (KR) 2018-10-04 US claimed
EP-3330273-A2 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND LG Chem, Ltd. (KR) 2018-06-06 EP claimed
US-20240400588-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA STEALTH BIOTHERAPEUTICS INC. (US) 2024-12-05 US disclosed
US-12037350-B2 Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia STEALTH BIOTHERAPEUTICS INC. (US) 2024-07-16 US disclosed
US-12037350-B2 Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia STEALTH BIOTHERAPEUTICS INC. (US) 2024-07-16 US disclosed
US-20240166618-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME GILGAMESH PHARMACEUTICALS, INC. (US) 2024-05-23 US disclosed
CN-111954848-B Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member DIC株式会社 2024-05-03 CN disclosed
CN-117642379-A Phenylalkylamines and methods of making and using the same 吉尔伽美什制药公司 2024-03-01 CN disclosed
EP-4305019-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME Gilgamesh Pharmaceuticals, Inc. (US) 2024-01-17 EP disclosed
EP-0647132-A1 GALENIC COMPOSITION FOR TOPICAL USE. LANCASTER GROUP AG (DE) 1995-04-12 EP disclosed
EP-0647131-A1 DERMATOLOGICAL AGENT FOR AIDING OXYGEN TRANSPORT IN THE SKIN. LANCASTER GROUP AG (DE) 1995-04-12 EP disclosed
EP-0647129-A1 TOPICAL APPLICATION COMPOSITION. LANCASTER GROUP AG (DE) 1995-04-12 EP disclosed
WO-1994000097-A1 TOPICAL APPLICATION COMPOSITION LANCASTER GROUP AG (DE) 1994-01-06 WO disclosed
WO-1994000109-A1 DERMATOLOGICAL AGENT FOR AIDING OXYGEN TRANSPORT IN THE SKIN LANCASTER GROUP AG (DE) 1994-01-06 WO disclosed
WO-1994000110-A1 GALENIC COMPOSITION FOR TOPICAL USE LANCASTER GROUP AG (DE) 1994-01-06 WO disclosed
US-4455441-A ALPHA-FLUORO-OMEGA HYDROXY STRAIGHT CHAIN HYDROCARBONS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1984-06-19 US disclosed
EP-0104880-A2 Attractant termiticidal compounds, compositions and methods of use therefor THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1984-04-04 EP disclosed